Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04187131 · ClinicalTrials.gov registry record · NA

An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation

A NA study of Stroke, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT04187131 is a NA study of Stroke that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 10 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04187131, a NA study of Stroke, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool.

Conditions Studied

Interventions

  • BEHAVIORAL augmented reality

Study Locations (2)

Massachusetts

  • Northeastern University - Boston

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-06-01
Est. Completion 2027-09-30
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT04187131

The ClinicalTrials.gov registry entry for NCT04187131 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which augmented reality is the first listed.

NCT04187131 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04187131 about?

NCT04187131 is a clinical study titled "An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation". The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool.

What is the current status of trial NCT04187131?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-06-01. Estimated completion is 2027-09-30.

What conditions does trial NCT04187131 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04187131?

The interventions under investigation include: augmented reality (BEHAVIORAL).

Who is sponsoring clinical trial NCT04187131?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04187131 being conducted?

This trial has 2 study locations across Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.